Celldex Therapeutics (CLDX) FCF Margin (QoQ) (2010 - 2026)
Celldex Therapeutics (CLDX) FCF Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Celldex Therapeutics | 1.72 Mn | 1.72 Mn | -1.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.44 Mn |
| Jun 30, 2025 | 173,363.00 |
| Mar 31, 2025 | -503,318.00 |
| Dec 31, 2024 | -107,702.00 |
| Sep 30, 2024 | -56,625.00 |
| Jun 30, 2024 | 2.51 Mn |
| Mar 31, 2024 | -2.55 Mn |
| Dec 31, 2023 | 45,870.00 |
| Sep 30, 2023 | 903,839.00 |
| Jun 30, 2023 | -728,585.00 |
| Mar 31, 2023 | -165,116.00 |
| Dec 31, 2022 | 736,772.00 |
| Sep 30, 2022 | 532,806.00 |
| Jun 30, 2022 | 37,095.00 |
| Mar 31, 2022 | -997,627.00 |
| Dec 31, 2021 | 636,738.00 |
| Sep 30, 2021 | -1.05 Mn |
| Jun 30, 2021 | 237,585.00 |
| Mar 31, 2021 | -257,861.00 |
| Dec 31, 2020 | 165,539.00 |